Cheng-Yu Wang

Cheng-Yu Wang

Auto-generated profile, based on publicly available information

Cheng-Yu Wang

Department of Cardiology, Peking University First Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GLGang Li
Gang Li
WLWen-Rui Li
Wen-Rui Li
YJYa-Ge Jin
Ya-Ge Jin
QJQi-Qiang Jie
Qi-Qiang Jie
CWCheng-Yu Wang
Cheng-Yu Wang
LWLin Wu
Lin Wu
Oxidative damage is closely involved in the development of doxorubicin‐ (DOX‐) induced cardiotoxicity. It has been reported that tetrandrine can prevent the development of cardiac hypertrophy by suppressing reactive oxygen species‐ (ROS‐) dependent signaling pathways in mice. However, whether tetrandrine could attenuate DOX‐related cardiotoxicity remains unclear. To explore the protective effect of tetrandrine, mice were orally given a dose of tetrandrine (50 mg/kg) for 4 days beginning one day before DOX injection. To induce acute cardiac injury, the mice were exposed to a single intraperitoneal injection of DOX (15 mg/kg). The data in our study showed that tetrandrine prevented DOX‐related whole‐body wasting and heart atrophy, decreased markers of cardiac injury, and improved cardiac function in mice. Moreover, tetrandrine supplementation protected the mice against oxidative damage and myocardial apoptotic death. Tetrandrine supplementation also reduced ROS production and improved cell viability after DOX exposure in vitro. We also found that tetrandrine supplementation increased nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) expression and activity in vivo and in vitro. The protection of tetrandrine supplementation was blocked by Nrf2 deficiency in mice. In conclusion, our study found that tetrandrine could improve cardiac function and prevent the development of DOX‐related cardiac injury through activation of Nrf2.

1 March 2010 in Dermatologica Sinica
Verified
Journal Article
Closed access
SLShang-Hong Lin
Shang-Hong Lin
CWCheng-Yu Wang
Cheng-Yu Wang
JHJi-Chen Ho
Ji-Chen Ho
WWWei-Ming Wu
Wei-Ming Wu
Drug-induced pseudolymphoma syndrome is a rare form of adverse cutaneous drug reaction. Its clinical and histological presentation may mimic mycosis fungoides, which sometimes leads to misdiagnosis and unnecessary treatments. We describe the case of a 65-year-old man with a generalized pruritic and confluent maculopapular eruption. His history of skin lesions was concordant with medication and resolved after discontinuation. However, microscopic examination showed characteristic features of mycosis fungoides, including Pautrier-like microabscesses and cerebriform nuclei of atypical lymphocytes. The immunohistochemical study showed CD4/CD8 infiltrate ratio to be 1 in the epidermis. The histopathological result of a second skin biopsy was compatible with drug eruption. This experience demonstrates that combining clinical history, histological and immunohistochemical findings is crucial for a definite diagnosis of PLS

1 January 2023 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
CXCheng Xu
Cheng Xu
ZWZichen Wang
Zichen Wang
CWChengyu Wang
Chengyu Wang
JLJie Lu
Jie Lu
QZQuanhong Zhou
Quanhong Zhou
Video 1 Details of ultrasound-guided linea semilunar block. Authors: Cheng Xu, Zichen Wang, Chengyu Wang, Jie Lu, Quanhong Zhou